Silica Nanoparticles as Promising Theranostic Platform
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 1894
Special Issue Editors
Interests: drug-delivery systems; mesoporous materials; inorganic nanoparticles
Special Issues, Collections and Topics in MDPI journals
Interests: mesoporous silica nanomaterials; drug delivery systems
Special Issue Information
Dear Colleagues,
Research interests in the medical field currently focus on the introduction of nanotechnology into the diagnosis and therapy of patients. The features of mesoporous silica nanoparticles, such as tunable pore size or particle shape and highly versatile surface properties, make them an ideal candidate for the identification and accommodation of biologically relevant molecules, thus assisting in patient diagnosis and treatment therapy.
This Special Issue aims to publish papers regarding the recent advances of mesoporous silica nanoparticles used in biomedical applications, such as drug delivery systems, targeted drug delivery, biomedical imaging, tissue engineering or pharmaceutical formulations based on silica nanoparticles.
Research areas include, but are not limited to, the design of silica nanoparticles or hybrid silica-based systems as nanoplatforms for various biologically active substances for diagnostics and treatment.
We invite you to submit original research, communications or critical review papers within the scope of this Special Issue.
We hope that this Special Issue will be a valuable source of progress in the development of silica-based theranostic platforms.
Prof. Dr. Daniela Berger
Dr. Mihaela Deaconu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mesoporous silica nanoparticles
- functionalized silica nanoparticles
- hybrid nanomaterials
- nanocomposites
- theranostics
- drug delivery systems
- synergic delivery systems
- tissue engineering
- targeted therapy
- biomedical imaging
- stimuli-responsive nanomaterials
